All In MedTech

Company

Tela Bio

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2023–$46.3M––
2022–$34.4M$40.0M–

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Jun 28, 2019Equity$10.6M$20.0M15Rule 506(b)Form D ↗Jul 10, 2019

11 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
TELA Bio, Inc.
Headquarters
Malvern, Pennsylvania
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Biotechnology

Executives, directors and promoters

As listed on the latest Form D.

    10 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is free with an account

    For Tela Bio we have 3 shareholders with 5% or more.

    Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.

    Latest FDA decisions

    Search the Clearance Tracker

    3 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    4 more trials with a free account

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230100
    Jan 240100
    Feb 241200
    Mar 240200
    Apr 240000
    May 240400
    Jun 240100
    Jul 240000
    Aug 240300
    Sep 240000
    Oct 240100
    Nov 240200
    Dec 240000
    Jan 250300
    Feb 250200
    Mar 250000
    Apr 250000
    May 250000
    Jun 250000
    Jul 250400
    Aug 250000
    Sep 250000
    Oct 250000
    Nov 250200
    Dec 250100
    Jan 260000
    Feb 260000
    Mar 260300
    Apr 260000
    May 260000
    Jun 260100
    Jul 260103
    Aug 260000
    Sep 260300
    Oct 260000
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    1 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    No recalls under this name in FDA's data.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.